"Performance" DAWNRAYS PHARMA's mid-term net profit is 105 million RMB, down 78.8%, with a dividend of 1.5 HK cents

阿斯達克財經網
2025.08.24 13:37
東瑞製藥 (02348.HK) 公佈 6 月止六個月中期業績，收入 6.3 億人民幣 (下同)，按年下降 9.2%。錄得純利 1.05 億元，倒退 78.8%，每股盈利 6.961 分。中期息維持派 1.5 港仙。
Source: 阿斯達克財經網 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.